Search

Recently, several reports have emerged describing the long-term consequences of COVID-19 that may affect multiple systems, suggesting its chronicity. As further research is needed, we conducted a longitudinal observational study to report the prevalence and associated risk factors of long-term health consequences of COVID-19 by symptom clusters in patients discharged from the Temporary COVID-19 Hospital (TCH) in Mexico City. Self-reported clinical symptom data were collected via telephone calls over 90 days post-discharge. Among 4670 patients discharged from the TCH, we identified 45 symptoms across eight symptom clusters (neurological; mood disorders; systemic; respiratory; musculoskeletal; ear, nose, and throat; dermatological; and gastrointestinal). We observed that the neurological, dermatological, and mood disorder symptom clusters persisted in >30% of patients at 90 days post-discharge. Although most symptoms decreased in frequency between day 30 and 90, alopecia and the dermatological symptom cluster significantly increased (p

We report two cases of primary psoas abscess in two patients of 15 months and 4 years of age. As the first case showed the natural history of this process the second one was large enough to produce a huge ureterohydronephrosis and to drain through the rectal wall to the rectum spontaneously, although this natural way did not achieve complete drainage. Both were treated by open drainage and systemic antibiotics with good response. They were discharged at the 7th and 12th postoperative day. 5 months later no complication has come up. Etiological, clinical and therapeutic aspects of this unusual pathology are reviewed.

Modern technologies require innovative approaches for controlled fabrication of crystalline materials with complex forms and novel properties [1-4]. Biomineralization is a widespread phenomenon among living systems (e.g., egg and mollusk shells, crustacea

A patient with gastroduodenal artery aneurysm detected with Tc-99m scintiangiography is described. Liver and hepatobiliary imaging were also performed on the patient. Ultrasound examination, arteriography, and surgical exploration were carried out. The value of radionuclide studies in leading to the proper diagnosis is emphasized.

ECMM ISHAM EFISG Astellas MSD Pfizer Christian Doppler Laboratory for invasive fungal infections Objectives: Invasive mold infections associated with Aspergillus species are a significant cause of mortality in immunocompromised patients. The most frequently occurring aetiological pathogens are members of the Aspergillus section Fumigati followed by members of the section Terrei. The frequency of Aspergillus terreus and related (cryptic) species in clinical specimens, as well as the percentage of azole-resistant strains remains to be studied. Methods : A global set (n = 498) of A. terreus and phenotypically related isolates was molecularly identified (beta-tubulin), tested for antifungal susceptibility against posaconazole, voriconazole, and itraconazole, and resistant phenotypes were correlated with point mutations in the cyp51A gene. Results : The majority of isolates was identified as A. terreus (86.8%), followed by A. citrinoterreus (8.4%), A. hortai (2.6%), A. alabamensis (1.6%), A. neoafricanus (0.2%), and A. floccosus (0.2%). One isolate failed to match a known Aspergillus sp., but was found most closely related to A. alabamensis. According to EUCAST clinical breakpoints azole resistance was detected in 5.4% of all tested isolates, 6.2% of A. terreus sensu stricto (s.s.) were posaconazole-resistant. Posaconazole resistance differed geographically and ranged from 0% in the Czech Republic, Greece, and Turkey to 13.7% in Germany. In contrast, azole resistance among cryptic species was rare 2 out of 66 isolates and was observed only in one A. citrinoterreus and one A. alabamensis isolate. The most affected amino acid position of the Cyp51A gene correlating with the posaconazole resistant phenotype was M217, which was found in the variation M217T and M217V. Conclusions : Aspergillus terreus was most prevalent, followed by A. citrinoterreus. Posaconazole was the most potent drug against A. terreus, but 5.4% of A. terreus sensu stricto showed resistance against this azole. In Austria, Germany, and the United Kingdom posaconazole-resistance in all A. terreus isolates was higher than 10%, resistance against voriconazole was rare and absent for itraconazole. Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria Hosp Santa Creu & Sant Pau, Serv Microbiol, Barcelona, Spain Univ Zaragoza, Hosp Univ Miguel Servet, IIS Aragon, Microbiol, Zaragoza, Spain Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, New Delhi, India Hamad Med Corp, Dept Lab Med & Pathol, Microbiol Div, Doha, Qatar Univ Copenhagen, Rigshosp, Dept Clin Microbiol, Unit Mycol,Statens Serum Inst, Copenhagen, Denmark Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy Univ Texas MD Anderson Canc Ctr, Houston, TX USA Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium Univ Integrata, Azienda Osped, Dipartimento Patol Diagnost, Unita Operat Complessa Microbiol & Virol, Verona, Italy Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria ASST Papa Giovanni XXIII, Microbiol Inst, Bergamo, Italy Univ Athens, ATTIKON Univ Hosp, Dept Internal Med 4, Infect Dis Res Lab, Athens, Greece Ca Granda Osped Maggiore Policlin, IRCCS Fdn, Lab Cent Analisi Chim Clin & Microbiol, Milan, Italy Univ Milan, Dept Biomed Sci Hlth, Milan, Italy Med Univ Vienna, Dept Lab Med, Div Clin Microbiol, Vienna, Austria Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany Publ Hlth England, Mycol Reference Lab, Bristol, Avon, England Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Natl Reference Med Mycol Lab, Belgrade, Serbia Univ Cologne, German Ctr Infect Res, Ctr Integrated Oncol CIO Koln Bonn,Clin Trials Ct, Dept Internal Med,Cologne Excellence Cluster Cell, Cologne, Germany ATTIKON Univ, Hosp Athens, Natl Kapodistrian Univ Athens, Clin Microbiol Lab, Athens, Greece Klinikum Wels Grieskirchen, Dept Hyg & Med Microbiol, Wels, Austria Div Microbiol, Dept Publ Hlth & Pediat, Turin, Italy Univ Hosp Cologne, Dept Internal Med, Cologne, Germany Partner Site Bonn Cologne, German Ctr Infect Res, Cologne, Germany Biometec Univ Catania, AOU Policlin Vittorio Emanuele Catania, Catania, Italy Univ Bologna, S Orsola Malpighi, Dept Med & Surg Sci, Infect Dis Unit, Bologna, Italy Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany Palacky Univ Olomouc, Fac Med & Dent, Dept Microbiol, Olomouc, Czech Republic Univ Hosp Olomouc, Olomouc, Czech Republic Univ Cadiz, Puerta Mar Univ Hosp, Clin Microbiol, Cadiz, Spain Hippokrateion Hosp, Aristotle Univ Sch Hlth Sci, Fac Med, Infect Dis Unit,Dept Pediat 3, Thessaloniki, Greece Hacettepe Univ Med Sch, Dept Med Microbiol, Ankara, Turkey Postgrad Inst Med Educ & Res, Dept Medial Microbiol, Div Mycol, Chandigarh, India Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil Univ Nacl Nordeste, CONICET, Inst Medicina Reg, Dept Micol, Resistencia, Argentina Vall Hebron Univ Hosp, Dept Microbiol, Div Clin Mycol, Barcelona, Spain Mazandaran Univ Med Sci, Dept Med Mycol & Parasitol, Invas Fungi Res Ctr, Sari, Iran European Univ Cyprus, Sch Med, Nicosia, Cyprus North Western State Med Univ, Dept Clin Mycol Allergy & Immunol, St Petersburg, Russia Univ Hosp Cologne, Dept Internal Med, Cologne, Germany Hacettepe Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Ankara, Turkey Iran Univ Med Sci, Sch Med, Dept Med Mycol & Parasitol, Tehran, Iran Hosp Ernest Lluch Martin, Dept Dermatol, Zaragoza, Spain Westerdijk Fungal Biodivers Inst, Dept Appl & Ind Mycol, Utrecht, Netherlands Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, Brazil Web of Science